Beijing Airdoc Technology Co., Ltd.

Equities

2251

CNE100004QQ9

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 04:08:35 2024-04-19 am EDT 5-day change 1st Jan Change
15.46 HKD 0.00% Intraday chart for Beijing Airdoc Technology Co., Ltd. -4.69% +27.77%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Beijing Airdoc Arm Setting Up 500 Million Yuan Fund MT
Beijing Airdoc Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Airdoc Technology's Employee Shareholding Trust Buys Additional Stock MT
Beijing Airdoc Technology Secures European Certification for Software Diagnostic Device MT
Beijing Airdoc Technology Co., Ltd. Announces Directors Appointment CI
Beijing Airdoc Technology Trustee Buys 787,700 Shares MT
Beijing Airdoc Technology Subscribes to $10 Million Worth of Wealth Management Product MT
Beijing Airdoc Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Beijing Airdoc Technology Forecasts Up to 68% Decline in H1 Loss MT
Beijing Airdoc Technology Co., Ltd. Announces Resignation of Zhu Tingyao as Non-Executive Director CI
Beijing Airdoc Invests in Prevention of Child’s Myopia and Amblyopia, AI-Powered Medical Devices MT
Beijing Airdoc Technology Co., Ltd. acquired Beijing Zhitong Technology Co., Ltd. CI
Airdoc Technology Acquires 70% Stake in Ophthalmic Device Manufacturer MT
Beijing Airdoc Technology Co., Ltd. Announces Executive Appointments CI
Beijing Airdoc Technology's 2022 Loss Widens; Shares Climb 7% MT
Beijing Airdoc Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Beijing Airdoc Technology Unit to Take Stake in IndexCap Partnership for $14.5 Million MT
Beijing Airdoc Technology Co., Ltd. Announces Director Resignations CI
Certain H Shares of Beijing Airdoc Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 6-NOV-2022. CI
Beijing Airdoc Technology Co., Ltd.(SEHK:2251) dropped from S&P Global BMI Index CI
Beijing Airdoc Technology Completes Clinical Trial for Diagnosis Software MT
Beijing Airdoc Technology Co., Ltd. Announces Completion of Airdoc-AIFUNDUS (2.0) Clinical Trialwith Outstanding Results CI
Beijing Airdoc Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Beijing Airdoc Technology Co., Ltd. Announces Management Appointments CI
Certain H Shares of Beijing Airdoc Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 5-MAY-2022. CI
Chart Beijing Airdoc Technology Co., Ltd.
More charts
Beijing Airdoc Technology Co Ltd is a China-based company that provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company's main product is Airdoc-AIFUNDUS 1.0. The Company's product can be used in the diagnosis of glaucoma, cataract, ICVD and ASCVD, diabetic retinopathy of pregnancy, hypertensive retinopathy of pregnancy and other diseases. In addition, the Company has developed a deep pipeline of other Software-as-a-medical devices (SaMDs) and health risk assessment solutions to address various healthcare needs for the whole population, including hospitals, community clinics, health checkup centers, insurance companies, optometry centers and pharmacies.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.29 CNY
Average target price
18.69 CNY
Spread / Average Target
+30.80%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2251 Stock
  4. News Beijing Airdoc Technology Co., Ltd.
  5. Beijing Airdoc Technology Completes Clinical Trial for Diagnosis Software